The most common prescription (98.4%) was for a combination of a cardiotonic, opioid and sedative drugs, according to the CDPH. Not every doctor writes them, however: There are more than 125,000 ...

In 2023, there were 1,281 prescriptions under the EOLA. The most common prescription (98.4%) was for a combination of a cardiotonic, opioid and sedative drugs, according to the CDPH. Not every doctor ...

Despite advancements in therapeutic approaches, the incidence and mortality associated with arrhythmia remain high, and drug-related adverse effects ... encompassing anti-arrhythmic, cardiotonic, anti ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. U.S. regulators are trying to shut down ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug ...

Chelsea Handler is no rookie when it comes to taking or sharing drugs with her celebrity pals. The “Fun Size” comedian opened up about her use of “natural drugs” and “micro-dosing ...

Obesity rates have been increasing in the US for decades, but in 2023 they fell – at least in part because of the burgeoning popularity of the “miracle drug” semaglutide. Approved for ...

Generic drug manufacturers have had to contend with increasing competition and tight profit margins in recent years. Slapping extra costs through tariffs could undermine their ability to do ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

Languages: English. President Donald Trump announced on Tuesday new measures to lower the costs of prescription drugs, which include increasing competition and creating transparency. Newsweek ...

“The Drug Testing Advisory Board was advisory in nature; it did not have regulatory authority over federal programs,” a SAMHSA spokesman told Transport Topics.